Exploration of Digital Health Technologies

Table 3. Loss to follow-up analysis (n = 101)^a.

Characteristics	Dropped out (n = 35)	Completed follow-up (n = 66)
Age (years)^b	22.31 ± 4.40	20.91 ± 3.80
Ethnicity^b
Caucasian origins	4 (11.4)	13 (19.7)
African origins	2 (5.7)	9 (13.6)
Asian origins	22 (62.9)	32 (48.5)
Other origins	7 (20.0)	12 (18.2)
Income^b
Below/Equal LICO^c	8 (22.9)	16 (24.2)
Above LICO^c	25 (71.4)	44 (66.7)
Prefer not to say	2 (5.7)	6 (9.1)
Place of residence^b
Greater Toronto Area	24 (68.6)	55 (83.3)
Other	11 (31.4)	11 (16.7)
Place of birth^b
Canada	23 (65.7)	44 (66.7)
Other	12 (34.3)	22 (33.3)
Personal chemical sensitivity diagnosis^b
Yes/Maybe	11 (31.4)	20 (30.3)
No	24 (68.6)	46 (69.7)
Household chemical sensitivity diagnosis^b
Yes/Maybe	13 (37.1)	23 (34.8)
No	22 (62.9)	43 (65.2)

Return to article view

^a: No statistically significant differences were reported in the baseline sociodemographic characteristics of participants who completed the study and those who dropped out; ^b: Continuous variables were reported as mean and standard deviations. Categorical data were presented as frequency and percentage; ^c: LICO stands for low-income cut-off.

Supplementary materials

The supplementary material for this article is available at: https://www.explorationpub.com/uploads/Article/file/101163_sup_1.pdf.

Declarations

Acknowledgements

We would like to thank the Women’s Healthy Environments Network for their ongoing consultations throughout this project.

Author contributions

GDM: Formal analysis, Investigation, Methodology, Visualization, Writing—original draft, Writing—review & editing. CB: Supervision, Conceptualization, Resources, Software, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing—original draft, Writing—review & editing. Both authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

Ethics approval for this research was received from the Ontario Tech University Research Ethics Board on 05 October 2023 [REB#17494] and complies with the Declaration of Helsinki.

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

The datasets from this study are available from the corresponding author, Graziella De Michino, upon request.

Funding

This study was funded by the SSHRC Small Grants Program 2023-Ignite Stream (Grant number not available). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Survey finds use of personal care products up since 2004-what that means for your health [Internet]. EWG, Environmental Working Group; c2025 [cited 2025 Jan 10]. Available from: https://www.ewg.org/research/survey-finds-use-personal-care-products-2004-what-means-your-health

Błędzka D, Gromadzińska J, Wąsowicz W. Parabens. From environmental studies to human health. Environ Int. 2014;67:27–42. [DOI] [PubMed]

Johnson PI, Favela K, Jarin J, Le AM, Clark PY, Fu L, et al. Chemicals of concern in personal care products used by women of color in three communities of California. J Expo Sci Environ Epidemiol. 2022;32:864–76. [DOI] [PubMed] [PMC]

What Are Parabens, and Why Don’t They Belong in Cosmetics? [Internet]. EWG, Environmental Working Group; c2025 [cited 2025 Jan 10]. Available from: https://www.ewg.org/what-are-parabens

Chatterjee S, Adhikary S, Bhattacharya S, Chakraborty A, Dutta S, Roy D, et al. Parabens as the double-edged sword: Understanding the benefits and potential health risks. Sci Total Environ. 2024;954:176547. [DOI] [PubMed]

Soni MG, Carabin IG, Burdock GA. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol. 2005;43:985–1015. [DOI] [PubMed]

Wan MLY, Co VA, El-Nezami H. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies. Crit Rev Food Sci Nutr. 2022;62:6549–76. [DOI] [PubMed]

Bräuner EV, Uldbjerg CS, Lim YH, Gregersen LS, Krause M, Frederiksen H, et al. Presence of parabens, phenols and phthalates in paired maternal serum, urine and amniotic fluid. Environ Int. 2022;158:106987. [DOI] [PubMed] [PMC]

Park NY, Cho YH, Choi K, Lee EH, Kim YJ, Kim JH, et al. Parabens in breast milk and possible sources of exposure among lactating women in Korea. Environ Pollut. 2019;255:113142. [DOI] [PubMed]

10.

Cherian P, Zhu J, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, et al. Amended Safety Assessment of Parabens as Used in Cosmetics. Int J Toxicol. 2020;39:5S–97S. [DOI] [PubMed]

11.

Huang K, Zhang X, Wang B, Wang X, You Y, Tang H, et al. Accurate assessment of parabens exposure in healthy Chinese female adults: Findings from a multi-pathway exposure assessment coupled with intervention study. Environ Res. 2021;193:110540. [DOI] [PubMed]

12.

Janjua NR, Frederiksen H, Skakkebaek NE, Wulf HC, Andersson AM. Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl. 2008;31:118–30. [DOI] [PubMed]

13.

Amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance) [Internet]. Commission Regulation (EU); [cited 2025 Jan 10]. Available from: https://www.legislation.gov.uk/eur/2014/1004/2020-01-31

14.

Scientific Committee on Consumer Safety (SCCS). OPINION on Methylparaben (CAS No. 99-76-3, EC No. 202-785-7). SCCS/1652/23. The European Commission; 2023.

15.

Cosmetic Ingredient Hotlist: Prohibited and Restricted Ingredients [Internet]. Government of Canada; [cited 2025 Jan 10]. Available from: https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/cosmetic-ingredient-hotlist-prohibited-restricted-ingredients.html

16.

Risk management scope for Parabens group [Internet]. Government of Canada; [cited 2025 Jan 10]. Available from: https://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/risk-management-scope-for-parabens-group-methylparaben-propylparaben-butylparaben-iso-butylparaben.html

17.

Parabens [Internet]. Government of Canada; [cited 2025 Jan 10]. Available from: https://www.canada.ca/en/health-canada/services/chemicals-product-safety/parabens.html

18.

Buchmüller K, Bearth A, Siegrist M. Consumers’ perceptions of chemical household products and the associated risks. Food Chem Toxicol. 2020;143:111511. [DOI] [PubMed]

19.

Llanos AAM, Rockson A, Getz K, Greenberg P, Portillo E, McDonald JA, et al. Assessment of personal care product use and perceptions of use in a sample of US adults affiliated with a university in the Northeast. Environ Res. 2023;236:116719. [DOI] [PubMed] [PMC]

20.

Trifunovski A, Rotondi NK, Abbass-Dick J, Barakat C. Analysis of Women’s Knowledge, Health Risk Perceptions, Beliefs and Avoidance Behaviour in Relation to Endocrine-Disrupting Chemicals in Personal Care and Household Products. Toxics. 2025;13:414. [DOI] [PubMed] [PMC]

21.

Cummings KM, Jette AM, Rosenstock IM. Construct validation of the health belief model. Health Educ Monogr. 1978;6:394–405. [DOI] [PubMed]

22.

Health belief model [Internet]. Wikipedia; [cited 2025 May 16]. Available from: https://en.wikipedia.org/wiki/Health_belief_model

23.

Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46:81–95. [DOI] [PubMed]

24.

Trifunovski A, Rotondi NK, Abbass-Dick J, Al Ghali R, Barakat C. The Development and Reliability Testing of a Tool to Assess Women’s Perceptions and Avoidance of Endocrine Disruptors in Personal and Household Products. Environments. 2025;12:138. [DOI]

25.

Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1:51–4. [PubMed] [PMC]

26.

Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13:92. [DOI] [PubMed] [PMC]

27.

Kim JH, Kwak JM, Kang H. Web-based behavioral intervention to reduce exposure to phthalate metabolites, bisphenol A, triclosan, and parabens in mothers with young children: A randomized controlled trial. Int J Hyg Environ Health. 2021;236:113798. [DOI] [PubMed]

28.

Hagobian T, Delli-Bovi Z, Mercado A, Bird A, Guy M, Phelan S. Development and feasibility of randomized trial to reduce urinary bisphenols in women with obesity. Pilot Feasibility Stud. 2021;7:24. [DOI] [PubMed] [PMC]

29.

Harley KG, Kogut K, Madrigal DS, Cardenas M, Vera IA, Meza-Alfaro G, et al. Reducing Phthalate, Paraben, and Phenol Exposure from Personal Care Products in Adolescent Girls: Findings from the HERMOSA Intervention Study. Environ Health Perspect. 2016;124:1600–7. [DOI] [PubMed] [PMC]

30.

Amico KR. Percent total attrition: a poor metric for study rigor in hosted intervention designs. Am J Public Health. 2009;99:1567–75. [DOI] [PubMed] [PMC]

31.

Arbour-Nicitopoulos KP, Sweet SN, Lamontagne M, Ginis KAM, Jeske S, Routhier F, et al. A randomized controlled trial to test the efficacy of the SCI Get Fit Toolkit on leisure-time physical activity behaviour and social-cognitive processes in adults with spinal cord injury. Spinal Cord Ser Cases. 2017;3:17044. [DOI] [PubMed] [PMC]

32.

Phillips LA, More KR. Evaluating behavior change factors over time for a simple vs. complex health behavior. Front Psychol. 2022;13:962150. [DOI] [PubMed] [PMC]